GlassScriptPhysician profile
Jacob Ivey
NPI 1891374302
$7,525.65
in general payments reported to CMS, 2019-2025
19 companies · $499 in 2025
The $499 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,344 · 2022: $2,831 · 2023: $1,522 · 2024: $1,329 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,018 · Travel and Lodging: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,018.32 |
| Travel and Lodging | $332.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reel Surgical, INC. | $3,652.61 | 2021-2025 | |
| Stryker Corporation | $2,082.36 | 2022-2024 | Augment Injectable, Citrefix, Prostep |
| Integra Lifesciences Corporation | $306.51 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $294.41 | 2022-2025 | Pico 14, Renasys Go V2 Home, Collagenase Santyl |
| Medline Industries LP | $195.00 | 2025 | |
| Treace Medical Concepts, INC. | $150.98 | 2022-2023 | |
| Linvatec Corporation | $142.66 | 2023 | Allograft Tissue |
| Bone Support INC. | $138.37 | 2024 | Cerament G, Ceramentbone Void Filler |
| Sanara Medtech INC. | $107.11 | 2024 | Texagen |
| Zimmer Biomet Holdings, INC. | $104.52 | 2025 | Accufill |
| Medtronic, INC. | $75.42 | 2024-2025 | In.Pact Admiral, Abre |
| Accufix Surgical INC. | $72.14 | 2025 | Accu-Joint |
| Orthofix Medical, INC. | $62.29 | 2023 | Physio-Stim |
| Zimvie INC. | $46.38 | 2023 | |
| Arthrex, INC. | $30.86 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $24.24 | 2024 | Exparel, Zilretta |
| Kerecis Limited | $17.76 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Mimedx Group, INC. | $13.28 | 2024 | |
| Reprise Biomedical, INC. | $8.75 | 2025 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Ivey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.